HB-10744 SH-3 鼠雜交瘤細(xì)胞 的詳細(xì)介紹

HB-10744 SH-3 鼠雜交瘤細(xì)胞

ATCC® Number: HB-10744™ Price: $399.00

Designations: SH3

Depositors: Osiris Therapeutics, Inc.

Isotype: IgG2b

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: suspension

Organism: Mus musculus （B cell）; Mus musculus （myeloma） （mouse （B cell）; mouse （myeloma））

Morphology: lymphoblast

Source: Cell Type: hybridoma: B lymphocyte;

Cellular Products: immunoglobulin; monoclonal antibody; against human mesenchymal stem cells

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Tumorigenic: Yes

Comments: Animals were immunized with human mesenchymal stem cells.

Spleen cells were fused with Sp2/0-Ag14 mouse myeloma cells.

The antibody reacts with mesenchymal stem cells from bone marrow and some tissues of mesenchymal origin.

Propagation: ATCC complete growth medium: Modified Dulbecco's medium, 85%; fetal bovine serum, 15%

Temperature: 37.0°C

Subculturing: Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 2 X 10 exp5 and 1 X 10 exp6 cells/ml.

Preservation: culture medium 95%; DMSO, 5%

Related Products: recommended serum:ATCC 30-2020

Recommended medium （without the additional supplements or serum described under ATCC Medium）:ATCC 46-X

References: 22086: Caplan AI, Haynesworth SE. Human mesenchymal stem cells. US Patent 5,486,359 dated Jan 23 1996

49752: Haynesworth SE, et al. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80, 1992. PubMed: 1316137